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Myeloid Sarcoma is a rare tumor composed of myeloblasts occurring at an extramedullary site like bones, or various soft tissues.
Myeloid sarcoma may involve the gastrointestinal tract very rarely either solitarily, or occurring simultaneously with acute myeloid
leukemia. Its diagnosis is challenging and needs biopsy and immunohistochemical staining. We are describing a case of myeloid
sarcoma which presented as a painful anal ulcer mimicking an atypical ﬁssure. Its appearance resembled crohn’s disease on
sigmoidoscopy. A biopsy of the ulcer along with histochemical staining led to the diagnosis of myeloid sarcoma. Our case
demonstrates the need for aggressive evaluation of any common gastrointestinal complaint with an atypical presentation.
1.Background
Myeloid Sarcoma, also know as, “Chloroma,” “Granulocytic
Sarcoma,” “Myeloblastoma,” or “extramedullary myeloid
tumor,” is a tumor formed by immature myeloid cells or
myeloblasts at an extramedullary site. Myeloid Sarcoma can
precede the onset of acute myeloid leukemia and can also
occur during active phase of leukemia. It may indicate
the relapse of leukemia in a previously treated patient, or
the blastic transformation of a chronic myeloid leukemia.
Head and neck structures, bones, oral cavity, soft tissues,
lymph nodes, skin, mediastinum, and reproductive organs
are frequent sites of involvement of myeloid sarcoma. The
involvement of the gastrointestinal tract is very rare. We
report a unique case of myeloid sarcoma presenting as a
large painful anorectal ulcer mimicking an anal ﬁssure and
Crohn’s disease in a young pregnant woman.
2.CaseReport
A 30-year-old pregnant Caucasian female complaining of
severe anal pain and an anal bump was referred to the
Colorectal Surgery Oﬃce by her primary care physician.
She was 8-week pregnant. Her pain started a few days
earlier and she noticed a small amount of bright red blood
on the toilet paper and coating the stools. She had been
constipated. She stated the pain was worse during and after
defecation. Her medical history was signiﬁcant for irritable
bowel syndrome, recurrent oral ulcers, and anal pruritis.
She denied abdominal pain, nausea, or vomiting. Her family
history was signiﬁcant for inﬂammatory bowel disease in her
maternal relatives. She denied any history of anal intercourse
or instrumentation.
Upon examination there were no signiﬁcant physical
ﬁndings with the exception of what appeared to be an atyp-
ical ﬁssure with heaped up skin edges and ulceration in the
center in the left posterior position. A local block was placed
and a steroid injection was performed. Topical lidocaine
mixed with diltiazem and high ﬁber supplementation were
prescribed.
Her pain transiently improved but upon repeat exami-
nation two weeks later she was having recurrent pain and
there was no change in the appearance of the ﬁssure. She was
admitted for pain control, an examination under anesthesia,
andaﬂexiblesigmoidoscopy.Thediﬀerentialdiagnosisupon
admission was new onset Crohn’s Disease or a severe anal
ﬁssure. Upon admission, her vitals were normal and anal
inspection revealed two large skin tags. A digital rectal
exam could not be done secondary to severe tenderness.
Labs showed normal serum electrolytes, WBC 3900, platelets
133000, Hb 11g/dL, Hct 31.5, and MCV 91.
She was taken to the operating room and examination
demonstrated a large deep anal canal ulcer in the left
posterior-lateral position (Figure 1). No obvious ﬁstula or2 Case Reports in Medicine
Figure 1: Large ano-rectal ulcer on exam under anesthesia.
abscess was identiﬁed. A sigmoidoscopy was performed and
revealed numerous aphthous erosions involving the mucosa
of the rectum and sigmoid colon, which appeared consistent
with inﬂammatory bowel disease. The proximal colon was
not evaluated endoscopically. Biopsies were taken from
the anal ulcer and rectosigmoid mucosa (Figure 3). An
additional steroid injection was given into the ulcer bed.
She was discharged home that day and was to follow up the
following week.
In the following few days, the results of the peripheral
blood smear and pathology returned. The smear contained
5%blasts.Thebiopsyfromtheanalulcerdepictedsquamous
mucosawithulcerationandsubmucosalatypicalhematopoi-
etic cell inﬁltrates suggestive of acute leukemia. Similar
ﬁndings of discrete mucosal and submucosal aggregates of
atypical large and medium-sized hematopoietic cells were
noted on rectal biopsies. She was immediately readmitted
and a bone biopsy was performed. Her results with ﬂow
cytometry showed hypercellularity with 53% blast cells. The
abnormal cells were positive for CD13 (58%), CD33 (73%),
CD15 (59%), CD45, CD34, CD64, CD4, HLA DR, and
MPO markers consistent with acute monocytic leukemia
(FAB M5b). Refer to Figures 2, 4, 5 and 6. Subsequent
cerebrospinal ﬂuid analysis also showed 30% blasts on ﬂow
cytometry. Her cytogenetic evaluation revealed an abnormal
female karyotype with Inv (16) (p13q22), and Trisomy 8 and
22.
She was diagnosed with acute myeloid leukemia and
started on high-dose Idarubicin and cytarabine for induc-
tion chemotherapy. Intrathecal methotrexate was also given
as there was evidence of central nervous system disease.
Her pregnancy was terminated therapeutically before the
chemotherapy was started. A repeat bone marrow biopsy
nine months later after completing chemotherapy did not
show any atypical cells. She clinically has no evidence of
disease at this time.
3. Discussion
Myeloid sarcoma is a tumor composed of immature myeloid
cells or myeloblasts at an extramedullary site often in close
proximity to bone. Myeloid sarcoma can occur as a solitary
mass or multiple nodules in diﬀerent tissues or organs such
Figure 2: Rectal biopsy showing mucosal and submucosal atypical
hematopoietic cell inﬁltration.
Figure 3: Anal ulcer biopsy showing atypical mucosal and submu-
cosal hematopoietic cell inﬁltration.
as skin, bone, head and neck structures, oral cavity, gingiva,
salivary glands, lymph nodes, central nervous system, and
genital tract, and rarely in the gastrointestinal tract [1,
2]. Myeloid sarcoma can occur concurrently with acute
myeloblastic leukemia in advanced stages. Skin and mucosa
are the most common sites of involvement. Sometimes,
myeloid sarcoma can be the initial presentation of blastic
transformation of a chronic myeloproliferative disorder or a
myelodysplastic syndrome [1, 3]. It has also been described
as a manifestation of relapse in patients with history of
priorsuccessfultreatmentofacuteorchronicleukemiasafter
bone marrow and stem cell transplantation [1, 4]. Isolated
myeloid sarcoma is rarely diagnosed in the absence of acute
myeloblastic leukemia. A diagnosis of acute myeloblastic
leukemia will be typically made a few months to years after
the diagnosis of myeloid sarcoma. The prognosis is poor
[5, 6].
The involvement of the gastrointestinal tract in diﬀerent
hematologic malignancies occurs at an advanced stage of
the disease or as a complication of chemotherapy and
radiotherapy. The most common ﬁndings on endoscopy
includes esophagitis, colitis, gastritis, gastric erosions, duo-
denitis, proctitis, and polyps [7]. Myeloid sarcoma involving
the gastrointestinal tract is very rare and can present withCase Reports in Medicine 3
Figure 4: Rectal ulcer biopsy under high magniﬁcation shows
atypical large and medium hematopoietic cells with large irregular
nuclei and pale cytoplasm. Scattered small lymphocytes and plasma
cells also seen.
Figure 5: Immunohistochemical marker staining.
abdominal pain, bleeding, perforation, obstruction, intus-
susception, liver infarction, pancreatitis, appendicitis, bile
duct obstruction, and portal hypertension [8–11]. CT
imaging might show focal bowel wall thickening, a single
mass, polyps, multiple masses obstructing the gut lumen, or
exophytic lesions involving the peritoneum [12]. There have
been cases of myeloid sarcoma localized to the oral cavity
[13], esophagus, stomach, jejunum [14–16], gallbladder
[17], bile ducts [18], pancreas [19, 20], colon [21], liver
[21], or appendix [22]o rm a yd i ﬀusely involve the GI tract
[23–25] including the abdominal wall [26]. When small and
large bowels are involved, it is more likely to spread to the
mesentery and peritoneum. The frequent involvement of
the ileum, appendix, and colon is likely secondary to the
widespread distribution of lymphoid tissue [8]. Our patient
has involvement of anus, rectum, and sigmoid colon.
Myeloidsarcomaposesasigniﬁcantdiagnosticchallenge.
Biopsy and staining with immunohistochemical markers
play a vital role. The immunophenotype is characteristic
based on whether myeloid sarcoma is granulocytic (MPO+,
Lysozymes+, CD34+/−), monoblastic (MPO−, CD68+,
Lysozyme−, CD34+), myelomonoblastic (MPO+/−, cd68+,
lysozyme+/−, CD34+/−), megakaryoblastic (Factor VIII+,
CD31+), or erythroblastic variant (glycoprotein c+) [1, 27].
It is diﬃcult to distinguish myeloid sarcoma from medium
sized or large cell non-Hodgkin’s lymphoma. In addition,
small round cell tumors, undiﬀerentiated carcinomas, and
extramedullary localizations of chronic myeloproliferative
Figure 6: Bone marrow biopsy showing hypercellularity and
atypical cells.
disorders also present signiﬁcant confusion [1, 27] during
diagnosis. The most frequent chromosomal abnormality is
t [8, 21] which our patient did not have. Patients with an
acute myeloblastic leukemia associated with t [8, 21]a n d
presenting with myeloid sarcoma have a low rate of complete
r e m i s s i o n ,a n do v e r a l ls u r v i v a li sp o o r[ 1, 28, 29]. Myeloid
sarcoma is treated with chemotherapy and local radiation
therapy when appropriate even there is no evidence of AML
on bone marrow evaluation.
The patient in this report presented with anal pain
which was initially presumed to be a ﬁssure and treated
accordingly. Her history of irritable bowel syndrome and her
familyhistoryofinﬂammatoryboweldiseasegavetheclinical
impression of Crohn’s Disease with an atypical anal ulcer. An
aggressive workup leading to admission and an examination
under anesthesia led to the “conﬁrmatory” diagnosis of
anorectal Crohn’s Disease. The smear and histopathology
with immunohistochemical markers diagnosed the myeloid
sarcoma. A subsequent bone marrow evaluation, CSF anal-
ysis with ﬂow cytometry, and cytogenetic studies conﬁrmed
the AML to allow initiation of treatment.
We did not ﬁnd any association of pregnancy with
increased incidence of myeloid sarcoma or acute myeloid
leukemia in our review. Though, myeloid sarcoma was
reportedtoinvolvethefemalegenitaltract[30–32]andpr eg-
nancy is associated with rapid maternal hematopoiesis, the
risk of acute myeloid leukemia in pregnancy is relatively very
rare[33,34].Wecameacrossonlyonecasereportofmyeloid
sarcomaoccurringinapregnantwoman[35]previously.The
patient in above case discussion was diagnosed with myeloid
sarcoma and AML in her ﬁrst trimester and her pregnancy
was terminated therapeutically.
It is unusual to ﬁnd a diagnosis of myeloid sarcoma and
AML with patients who present with common gastrointesti-
nal problems. Our case illustrates the need for aggressive
evaluation in any patient presenting with atypical gastroin-
testinal complaints.
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